Table 4 Hazard ratios for death (analysis from time of diagnosis)

From: Treatment decisions and survival for people with small-cell lung cancer

Survival from diagnosis

Total patients N =15 091

Deaths n =10 041

%

HR

95% CI

Adjusted HR a

95% CI

Townsend quintile

1 (Least deprived)

2111

1981

93.8

1.00

 

1.00

 

2

2704

2558

94.6

1.02

0.96–1.08

1.03

0.98–1.10

3

2958

2788

94.3

1.02

0.96–1.08

1.01

0.95–1.07

4

3307

3109

94.0

1.01

0.95–1.06

1.03

0.98–1.09

5 (Most deprived)

3738

3517

94.1

0.99

0.94–1.05

1.02

0.96–1.08

Missing

273

262

96.0

1.69

1.49–1.93

1.39

1.22–1.58

Route of referral

Emergency admission

2323

2246

96.7

1.69

1.61–1.78

1.30

1.24–1.37

General Practitioner

7267

6738

92.7

1.00

 

1.00

 

Consultant referral

2729

2566

94.0

1.19

1.14–1.25

1.01

0.96–1.06

Other (inc private)

887

836

94.3

1.18

1.10–1.27

1.03

0.96–1.11

Emergency Department

1120

1086

97.0

1.66

1.56–1.77

1.29

1.21–1.37

Missing

765

743

97.1

1.26

1.17–1.36

1.12

1.04–1.21

Radiotherapy

No chemotherapy

4509

4448

98.6

1.00

 

1.00

 

Chemotherapy only

9590

8962

93.5

0.28

0.27–0.29

0.35

0.34–0.37

Chemo-radiotherapy

992

805

81.1

0.16

0.15–0.18

0.26

0.24–0.28

Chemotherapy cycles

No chemotherapy

4509

4448

98.6

1.00

 

1.00

 

1–3 cycles

3228

3115

96.5

0.45

0.43–0.47

0.54

0.52–0.57

4 cycles

5540

4936

89.1

0.20

0.19–0.21

0.25

0.24–0.27

NLCA record only

1814

1716

94.6

0.31

0.29–0.33

0.39

0.37–0.41

Time to treatment

<18 days

5137

4834

94.1

1.00

 

1.00

 

18 days

5445

4933

90.6

0.80

0.77–0.83

0.84

0.81–0.88

No chemotherapy

4509

4448

98.6

3.30

3.17–3.44

2.64

2.52–2.76

Trust first seen

Non-chemotherapy trust

4276

4011

93.8

1.00

 

1.00

 

Chemotherapy trust

10 779

10 171

94.4

1.01

0.97–1.04

0.99

0.95–1.02

Missing/trust that saw <20 cases

36

33

91.7

0.99

0.70–1.39

0.93

0.66–1.32

  1. Abbreviations: CI=confidence interval; HR=hazard ratio; NLCA=National Lung Cancer Audit.
  2. aAdjusted for sex, age, performance status, co-morbidity index and stage.